for Jan 24, 2023 through Jan 30, 2023
BREAKING:
— Dr Aseem Malhotra (@DrAseemMalhotra) January 24, 2023
According to a survey in USA estimated number of deaths due to covid 19 vaccines could be as high as 278,000 with 1 MILLION serious adverse events in 2021
These findings ‘should be fully investigated’ say authors in BMC Infectious Diseases. https://t.co/mh6wn0e41k
🔥NEW🔥 @PharmacoJournal@LinaMengPharmD @DHpharmd@EmilyMui @StanDeresinski @StanfordASP
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 27, 2023
Comprehensive Guidance for Antibiotic Dosing in Obese Adults: 2022 Update #IDTwitter
cc @SIDPharm @accpinfdprn @IDstewardship @InfectiousDz @DosingMatters #paywall☹️https://t.co/otqUjYoMn5
🔥Wow🔥
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 25, 2023
🆕️Retrospective cohort @CIDJournal @IDpharmresearch
High Dose Cefepime Vs Carbapenems for Bacteremia Caused by Enterobacterales with Moderate to High Risk of Clinically Significant AmpC β-lactamase Production
Similar risk of 30d mortality!
RCT? https://t.co/pafpQPxGVB pic.twitter.com/rP1k7QuIQT
Congratulations @IDdocChen @HHoangMD @carliocer et al: RCT of antimicrobial stewardship intervention in patients hospitalised w/COVID-19 in @TheLancetInfDis @UofA_ID @UAlberta_DoM @UAlberta_FoMD https://t.co/D7b9cGRzx4
— UofA Infectious Diseases (@UofA_ID) January 27, 2023
Just out in @CIDJournal: Further evidence of the interplay between host immune status and variant in development of one of the most dreaded long covid symptoms -- prolonged severe fatigue. Vaccination associated with reduced risk. https://t.co/udroO6c4Qt pic.twitter.com/A6ktggmgpW
— Paul Sax (@PaulSaxMD) January 30, 2023
I’m pleased the editors of the journal BMC Infectious Diseases added an Editor’s Note to this dreadful paper, written & funded by well known anti-vaccine activists. I’m pleased they’re investigating how this screw-up happened
— Prof Gavin Yamey MD MPH (@GYamey) January 30, 2023
It should be retracted asaphttps://t.co/CMzb4xYv6i
🙌 “Implementing a real-time EHR antimicrobial report run by pharmacists in the ED was associated with significantly fewer major delays in subsequent antibiotic dosing following a first dose.” via @AJHPOfficial https://t.co/rFAVmaBrGI #EMtwitter #TwitteRx @accpemedprn pic.twitter.com/iQD6TABmUX
— ACCP INFD PRN (@accpinfdprn) January 27, 2023
REMEMBER WHEN "MASKS STOP VIRUSES" WAS "FAKE NEWS"?
— Paul D. Thacker (@thackerpd) January 28, 2023
Sydney Morning Herald: "Those masks are only effective so long as they are dry," said Professor Yvonne Cossart of the Department of Infectious Diseases at the University of Sydney. https://t.co/XzeZSECJxY @MaryanneDemasi
Uncomplicated Streptococcal Bacteremia: The Era of Stepdown to Oral Antibiotic Therapy? https://t.co/mExF1xLSZw pic.twitter.com/CF3vM9X2y2
— Tristan Timbrook (@TristanTimbrook) January 27, 2023
In the presence of antidepressants, the Gram-negative bacteria, E. coli, can develop #AntibioticResistancehttps://t.co/W36lbDAWbq
— MicrobesInfect (@MicrobesInfect) January 25, 2023
📄 New article in @AJHPOfficial: “…resulted in increased use of β-lactam antibiotics, decreased use of second-line antibiotics, and decreased costs without a significant change in the incidence of adverse reactions.”https://t.co/Ca5A8WjMe6 #TwitteRx #MedTwitter pic.twitter.com/bdOHMRFuYJ
— SIDP (@SIDPharm) January 27, 2023
It's flu season! This #ClinMicroRev article describes current FDA-approved influenza antivirals, viral- and host-directed antiviral approaches and the potential utility of machine learning in developing next-generation antivirals against influenza. https://t.co/lUkNW4XTSL pic.twitter.com/Neverht1BP
— ASM (@ASMicrobiology) January 25, 2023
New research: Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trialhttps://t.co/RYiB60Q40Q pic.twitter.com/sR6IEncrV5
— The Lancet Infectious Diseases (@TheLancetInfDis) January 30, 2023
The role of social circle COVID-19 illness and vaccination experiences in COVID-19 vaccination decisions: an online survey of the United States population | BMC Infectious Diseases | Full Text https://t.co/CfPqczTEUX
— Dr Jordan B Peterson (@jordanbpeterson) January 24, 2023
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection: 152-week results from ATLAS-2M, a randomized, open-label, Phase 3b, noninferiority study https://t.co/hog4n00N9v CAB+RPV LA q 4 or 8 weeks leads to virologic suppression. @CIDJournal
— Carlos del Rio (@CarlosdelRio7) January 24, 2023
We now need a proper RCT!
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 24, 2023
🆕️⚡️Multicentre retrospective observational cohort study
Carbapenem treatment may be SUPERIOR to BLBLI treatment for
▶️IMMUNOCOMPROMISED ▶️patients suffering from cUTIs caused by Ceftriaxone-non-susceptible Enterobacteraleshttps://t.co/ekOgM16nfg
🆕️⚡️⚡️ #JAK
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 24, 2023
Systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis #IDTwitter #wikiguidlines #paywall ☹️https://t.co/9j1Zi2KngZ
Antibiotic #stewardship programs should consider targeting social determinants of health along with underlying health conditions of patients being treated with antibiotics➡️does poverty ⬆️ abx prescribing rates through underlying health conditions?
— ASHE Journal (@ASHE_Journal) January 30, 2023
https://t.co/7L7Na8b0wl
BMC Infectious Diseases Journal published a paper by Prof Mark Skidmore an economist at Michigan State University.
— David Atherton (@DaveAtherton20) January 30, 2023
In it he claims 280,000 people have died of the covid vaccine. https://t.co/jQhWycpCO2
But why should we care about ventilation & indoor air quality?
— Cat | CC14 🐈⬛🇬🇧 (@CC14_CC14) January 28, 2023
Good ventilation can:
📍reduce transmission of ALL airborne diseases (covid, flu, RSV etc)
📍reduce staff & pupil absences
📍 improve cognitive function & test scores
📍reduce asthma symptomshttps://t.co/h4SmrX0nWe pic.twitter.com/No8s6MzqrY
Congratulations to Dr. Carlos Del Rio for becoming the Interim Emory SOM Dean and Chief Academic officer for Emory Healthcare on March 1st!
— Woodruff Health Sciences Center Library (@EmoryHealthLibr) January 27, 2023
image: https://t.co/d472wItyro
@@CarlosdelRio7 @emoryhealthcare @emoryhealthsci @EmoryMedicine @EmoryNursing @EmoryRollins @EmoryUniversity pic.twitter.com/MY5BBG1RVC
🆕️⚡️⚡️Infective Endocarditis After Transcatheter Aortic Valve Replacement: @JACCJournals State-of-the-Art Review#WikiGuidelines @DrEmilyMcD @DrToddLee @BradSpellberg #IDTwitter #cardiotwitter #TAVRhttps://t.co/RXlkenugrD pic.twitter.com/EEu3hq0cwN
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 28, 2023
Trial begins for bacteriophage cocktail in cystic fibrosis patients
— CIDRAP (@CIDRAP) January 24, 2023
The trial is evaluating whether a #bacteriophage cocktail can safely reduce a bacterium that causes lung infections in CF patientshttps://t.co/OXMWFOU04C#AMR #AntibioticStewardship @CIDRAP_ASP
Impact of Vaccination on Cost and Course of Hospitalization Associated with #COVID19 Infection #vaccines
— ASHE Journal (@ASHE_Journal) January 25, 2023
📄 https://t.co/5rqwyjQTnl pic.twitter.com/Qw3bMAIIrq
The final first author paper of my #PhD at @EmoryMMG is now online at #MicrobiologySpectrum! @ASMicrobiology @JournalSpectrum @rpetit3 #bacteriology #visa #staphylococcusaureus #infectiousdiseases #nanopore #amplicon https://t.co/dZ5KAfAiqW
— Abraham Moller, PhD (@abraham_moller) January 27, 2023
BREAKING:
— Dr Aseem Malhotra (@DrAseemMalhotra) January 24, 2023
According to a survey in the US alone estimated number of deaths due to covid 19 vaccines could be as high as 278,000 with 1 MILLION serious adverse events.
These findings ‘should be fully investigated’ say authors in BMC Infectious Diseases. https://t.co/mh6wn0e41k
New Grand Round: Novel severe oculocutaneous manifestations of human monkeypox virus infection and their historical analogueshttps://t.co/kbLXk8haBv
— The Lancet Infectious Diseases (@TheLancetInfDis) January 24, 2023
[Content warning: potentially upsetting clinical images] pic.twitter.com/qNfkk92wRA
🆕️⚡️⚡️systematic review & meta-regression analysis
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 30, 2023
Incidence of infection with MDR Gram-negative bacteria & VRE in carriers
The pooled cumulative incidence of infection was 14% at a median follow-up time of 30d for MDR-GNB & 8% at 30d for VRE #IDTwitterhttps://t.co/3ygIxB6pZC
New "Osterholm Update: COVID-19" podcast! @mtosterholm & @cvdall discuss the state of the pandemic in the US and globally, the latest on XBB.1.5, and a measles outbreak in Ohio. Also: COVID death count, flu & RSV, and antibiotic-resistant gonorrheahttps://t.co/1H3NaPC7R3 pic.twitter.com/2bEchHooIC
— CIDRAP (@CIDRAP) January 26, 2023
🔥BREAKING🔥
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 26, 2023
FDA announces Evusheld is not currently authorized for emergency use in the U.S @InfectiousDz @IDstewardship @DrToddLee #IDTwitter https://t.co/3oqLcjXeAz
Japan has decided to downgrade COVID-19 to the same category of infectious diseases as seasonal influenza on May 8.https://t.co/UrfVfHCqFT
— NHK WORLD News (@NHKWORLD_News) January 27, 2023
New research in @mbiojournal shows that E. coli-derived extracellular vesicles (EVs) lead host cells to release EVs that enhance inflammatory responses, thus providing a novel example whereby bacterial EVs transduce biological signals to mammalian EVs. https://t.co/hb8gGphfU2 pic.twitter.com/PMLfTIhnif
— ASM (@ASMicrobiology) January 25, 2023
Read our February issue! Featuring BA.5 infections in Denmark, RCT to reduce antibiotic use in hospital, and influenza in vaccinated people in Latin Americahttps://t.co/3p8ZzgLYCY pic.twitter.com/oZ2qvgVfdl
— The Lancet Infectious Diseases (@TheLancetInfDis) January 30, 2023
Researchers develop a spray with antimicrobial peptides that can kill antibiotic-resistant bacteria, & that can be used for wound care & directly on implants & other medical deviceshttps://t.co/wwonXfkluC
— MicrobesInfect (@MicrobesInfect) January 28, 2023
📄 New in @ICHEJournal — “…SSTOP may serve to achieve sustainable promotion of antibiotic use improvements.”
— ACCP INFD PRN (@accpinfdprn) January 27, 2023
Great work from @VAStewie folks on a project years in the making. Congrats! 👏👏👏
📲 https://t.co/hqbVwRFke6 #IDtwitter #ASPtwitter #SaveABX pic.twitter.com/qFRttZ6ASk
For anyone who finds this topic particularly interesting, I want to remind everyone that CIDRAP has a podcast called “Superbugs and You” that covers #antimicrobialresistance, with stories from patients, physicians, and researchers from around the world. https://t.co/gvbCLd2anA
— Michael Osterholm (@mtosterholm) January 27, 2023
This E-learning module aims to increase your knowledge in the identification, prevention and management of wound infection incorporating the concepts of Antimicrobial Resistance and Stewardship.
— EWMA (@EWMAwound) January 26, 2023
Access the course 👇https://t.co/RmfQCgVJy4#Wound #Infection #Elearning pic.twitter.com/fyLkTZiYhl
🆕️⚡️ @OFIDJournal
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 25, 2023
Real-world use of bezlotoxumab and fecal microbiota transplantation for the treatment of Clostridioides difficile infection #IDTwitter https://t.co/QLm5YZisyR pic.twitter.com/hQOdVu2P6z
🆕️⚡️⚡️ @OFIDJournal@mcastanheirajmi
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 27, 2023
Trends of β-Lactamase Occurrence among Escherichia coli and Klebsiella pneumoniae in United States Hospitals during a 5-year period and Activity of Antimicrobial Agents against Isolates Stratified by β-Lactamase Type1 https://t.co/0TEssZxoLo
"Various outcomes have been reported for hospital #AntimicrobialStewardship interventions. Patient self-reported outcomes are under-reported"
— JAC-AMR (@jac_amr) January 26, 2023
Read this review of systematic reviews by @shaziaYousuf11 @RzewuskaM @EilidhMDuncan @ProfRamsay:https://t.co/Tt4X5mf5Q4#JACAMRNews
🆕️⚡️@ASHE_Journal @SHEA_Epi
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 30, 2023
Impact of phenotypic rapid diagnostic assay *Accelerate PhenoTest * with (AMS) on duration of empiric antibiotics for gram-negative bacteremia
Duration of empiric antibiotics decreased in RDT+AMS (4d vs 2 d) more👇 #IDTwitter https://t.co/XHY6fQd3xl pic.twitter.com/sGI1wNxkGx
Introducing PhyloPlus! A new web portal allowing users to generate custom phylogenies that may be applied to any data set. The tool will help facilitate use of phylogeny-based approaches in metagenomic data analyses. Learn more in @mbiojournal: https://t.co/sLXNNRVJ7y pic.twitter.com/yNYxKzu1Du
— ASM (@ASMicrobiology) January 24, 2023
Plant toxin hailed as ‘new weapon’ in antibiotic war against bacteria.
— MicrobesInfect (@MicrobesInfect) January 29, 2023
The new antibiotic (#albicidin) is produced by the plant pathogen Xanthomonas albilineans & attacks bacteria in a different way to existing drugs.https://t.co/JuW0bCepgT
Study comparing effectiveness of #bivalent BA.4-5 & BA.1 mRNA-booster vaccines showed bivalent booster as a 4th #COVID19 vaccine dose boosted protection against #SARSCoV2-related hospitalization & mortality compared to triple-vaccinated individuals.https://t.co/Kr27hK501A
— MicrobesInfect (@MicrobesInfect) January 24, 2023
I would like to thank my team lead by @Uwolivier14 founder of @OliHealthOrg today marking my first publication.
— Deusdedith B. Bulimbe🇹🇿 (@Deus_Wabonny) January 26, 2023
I would love you read
The insight through the current immunotherapeutic guidelines for infectious
diseases
International Journal of Surgery https://t.co/h7eA0duYg5
Antivaxxers love surveys. This time @BioMedCentral Infectious Diseases somehow published a truly awful one by an economist named Mark Skidmore that claims that #CovidVaccines have killed nearly 300,000 people. https://t.co/dKLTJ3DTuQ
— David Gorski, MD, PhD (@gorskon) January 25, 2023
Protist predation is a major cause of bacterial mortality in the environment. In @JournalSpectrum, researchers show that the oligosaccharide region of LPS governs predation of E. coli by the bacterivorous protist, Acanthamoeba castellanii. https://t.co/RSsVxGBctL pic.twitter.com/jbdqj5Ei42
— ASM (@ASMicrobiology) January 24, 2023
How antidepressants help bacteria resist antibiotics https://t.co/sWb4rtKd7i
— Stop Superbugs (@TheUrgentNeed) January 25, 2023
Devon #care #homes say they are being asked to accept patients with #Covid-19, flu and other infectious diseases to ease the pressure on local hospitals.🫤https://t.co/vpQpB1sW1s
— Amanda Tomlins😷🐾🇪🇺🏳️🌈Still Shielding (@tomlins_amanda) January 27, 2023
I am happy to welcome my new PhD student Lara Bastos to our group. She will be working on a predictive algorithm for when #antibiotic treatment benefit cows affected with #mastitis. https://t.co/uOo9NmWOgd pic.twitter.com/3zMiAXyqjS
— Pamela Ruegg, DVM, MPVM (@topmilk) January 26, 2023
Marburg virus vaccine shows promising results in first-in-human study. This 1st-in-human Phase 1 study tested an experimental vaccine candidate, known as cAd3-Marburg. The vax was developed at Nat'l Institute of Allergy and Infectious Diseases https://t.co/iK2UiuUH1u
— delthia ricks 🔬 (@DelthiaRicks) January 30, 2023
Created by Cameron Forbes. Last updated January 31, 2023 at 05:16 EST.